Clinical Trial Update: Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether infrared laser spectroscopy analysis of liquid biopsies can predict the efficacy of palbociclib in combination with le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: International Cancer Research Group, United Arab Emirates | Conditions: Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer | Phase 2 | Status: RECRUITING